VRSK: Verisk Analytics Outlook & Valuation
Verisk (VRSK) delivered a Q4 beat and launched a $1.5B accelerated share repurchase, while trading well below its 52-week high. This report weighs growth prospects, valuation and risks ahead of May earnings.
Executive Summary
Investment Thesis: Verisk ($VRSK) remains a leader in insurance and risk analytics with recurring software and data subscription revenues, high margins, and free cash flow that underpins shareholder returns. Recent catalysts include a Q4 2025 earnings beat and a $1.5 billion accelerated share repurchase program that signals capital allocation flexibility. That said, valuation is elevated relative to historical averages and peers, and the stock has materially underperformed the Nasdaq since the 2025 high, which raises questions about growth runway versus cash return priorities.
Current Price: $201.22 | Key Metric: P/E 30.04 | Stance: NEUTRAL
Company Overview
Verisk Analytics, Inc. provides data analytics, predictive modelling, and decision support for the insurance, natural resources, financial services and government markets. The firm is best known for underwriting, claims and catastrophe risk models that large insurers and reinsurers rely on to price and manage exposure.
Key Products & Competitive Position
- Core Business: Subscription and analytics products for insurance underwriting, pricing and claims, plus specialized solutions for catastrophe modelling, life insurance and other verticals.
- Key Products: Underwriting data and rules, loss costs and forms, catastrophe models, claims analytics, and industry-specific decisioning tools delivered via software and data feeds.
- Competitive Moat: Proprietary datasets, long-term client relationships with high switching costs, regulatory embeddedness in insurance workflows, and domain expertise across risk modelling and actuarial science.
Recent Developments
Verisk presented at the BofA Information & Business Services Conference in March 2026, highlighting product roadmaps and client adoption trends. In early March the company entered accelerated share repurchase agreements totaling approximately $1.50 billion, a major capital allocation move. Q4 2025 results showed an EPS beat, supporting organic profitability. Market commentary has noted that VRSK has lagged the Nasdaq, though analysts remain broadly constructive.
Financial Snapshot
Revenue & Earnings Trends
Verisk generates a high proportion of recurring subscription and data revenues, which supports margin stability. Management has shown consistent margin expansion through pricing, cross-selling and operating leverage. Q4 2025 EPS of $1.82 beat the estimate of $1.6409, which suggests continued execution on cost and revenue drivers. Organic top-line growth has alternated between steady midsingle-digit rates and pockets of acceleration tied to product cycles and new contracts.
Balance Sheet Highlights
The balance sheet is generally sound with a current ratio of 1.20 implying adequate near-term liquidity. Verisk has capacity to fund bolt-on M&A and share repurchases. The recent $1.5 billion accelerated buyback used available liquidity and financing capacity, reflecting confidence in cash generation. Investors should track leverage metrics as the buyback progresses.
Valuation Analysis
Current Valuation Metrics
Historical Comparison
Current trailing P/E of 30.04 sits above a likely 5-year average in the mid-20s, reflecting premium multiple expansion during prior growth phases. EV/EBITDA is above historical norms, indicating the market prices durable margins and recurring revenue. The stock's pullback from the $322.92 52-week high has reset part of the multiple, but valuation remains elevated versus many industrial software peers.
Fair Value Estimate
Balancing recurring revenue growth, high operating margins and strong cash flow against a stretched PEG and limited near-term organic growth acceleration, a reasonable fair value range lies near the consensus analyst mean of roughly $246 per share. That price reflects about a 23x forward P/E on expected mid-single-digit revenue growth and continued margin conversion, adjusted for buyback-driven EPS accretion.
Competitive Landscape
Market Position
Market Share: ~20% (estimated in core insurance analytics) | Ranking: #1 provider for core insurance underwriting analytics
Key Competitors
Competitive Advantages
- Moat 1: Proprietary, high-quality datasets that are costly to replicate and essential to underwriting workflows.
- Moat 2: Embedded relationships with insurers and regulators, creating high switching costs and steady renewal rates.
- Moat 3: Domain expertise in catastrophe and actuarial modelling, which drives differentiated product value and pricing power.
Earnings Track Record
Last 4 Quarters: 3 beats / 1 misses
Recent Earnings History
Guidance Trend
Management has maintained a focus on recurring revenue growth, margin improvement and shareholder returns. Guidance has been generally steady with modest upward revisions following execution beats. Investors should watch Q1 2026 guidance for signs of acceleration or conservatism tied to underwriting cycles and macro trends.
Analyst Sentiment
Consensus Rating:
Price Targets
- Low: $195
- Mean: $245.81 (+22% upside)
- High: $300
Recent Analyst Actions
Analysts have maintained an overall Buy consensus while trimming some price targets amid slower sector multiples and macro uncertainty. Wells Fargo and other firms have kept constructive outlooks but lowered targets from 2025 highs. Expect further target revisions tied to buyback pace and Q1 2026 results.
Recent News & Catalysts
Key Developments
- BofA Conference (3/12/2026): Management outlined product priorities and client demand trends, reinforcing subscription revenue resilience.
- Underperformance vs Nasdaq (3/11/2026): Commentary highlighted persistent relative weakness despite solid fundamentals, keeping sentiment mixed.
- $1.5B Accelerated Buyback (early March 2026): Agreements with HSBC and Wells Fargo to repurchase shares; initial tranche received, signaling capital return focus.
- Geopolitical Volatility (3/10/2026): Broader market weakness affected professional services names, causing intraday pressure on VRSK with peers like SAIC and CoStar also moving.
- Comparative Valuation Stories (3/10/2026): Media pieces compared VRSK to peer FDS for value relative to growth profiles.
Upcoming Catalysts
Next Earnings: 2026-05-05 Before Market | Key Events: Q1 2026 results and guidance, buyback progress updates, analyst note revisions.
Technical Outlook
Current Price: $201.22 vs 52-Week High: $322.92 (-37.7% from high)
Trend Analysis
The stock has fallen significantly from the 2025 peak and staged a recovery after the February 2026 low of $164.60. Momentum has improved in the short term, but price remains below the previous highs and appears range-bound while investors reassess growth versus buyback-driven EPS. Lower beta of 0.79 suggests VRSK will likely move less than the market in periods of volatility.
Key Levels
- Resistance: $240, $280
- Support: $180, $165
Bull vs Bear Case
Bull Case
- Catalyst 1: Continued execution on subscription growth and cross-sell lifts revenue, driving margin expansion and EPS upside.
- Catalyst 2: Aggressive buybacks reduce share count and boost EPS, making multiples more attractive over time.
- Catalyst 3: Market underappreciates durable pricing power in insurance verticals, leaving upside to the consensus target.
Bull Target: $300 (+49%)
Bear Case
- Risk 1: Stagnant organic growth forces reliance on buybacks to drive EPS, masking weakening fundamentals.
- Risk 2: Valuation compression if macro or insurance cycles deteriorate, dragging multiples lower.
- Risk 3: Competitive pressure or data privacy regulation could increase costs or slow new product adoption.
Bear Target: $160 (-20%)
Risks to Consider
- Valuation Risk: High trailing P/E and P/S imply limited margin for error. If revenue slows, multiples could contract materially.
- Competitive Risk: Niche analytics and data providers plus big tech entrants could pressure pricing or accelerate feature parity.
- Macro Risk: Insurance cycles, interest rate moves and geopolitical shocks can influence client budgets and deal timing.
- Execution Risk: Integration of new products, maintaining data quality and delivering model improvements are central to client retention.
Bottom Line
Investment Verdict: NEUTRAL
Verisk is a high-quality, cash-generative analytics business with durable client relationships and a strong franchise in insurance data. Recent earnings and the $1.5 billion ASR are supportive, yet lofty valuation metrics and a mixed growth signal mean upside is not guaranteed. Analysts' consensus remains Buy with a mean target near $246, but you should expect volatility as the market digests buyback impact and upcoming guidance.
Action Items for Investors
- Long-term investors: Monitor organic revenue growth, renewal rates and buyback progress to assess whether EPS gains are sustainable or primarily capital-return driven.
- Short-term traders: Watch for Q1 2026 earnings on 2026-05-05 and any guidance shifts, which could trigger re-rating or headline volatility.
- Risk management: Consider position sizing that reflects elevated valuation, and set stop or re-evaluation points around the $165-$180 support band.
What to Watch This Week
- Analyst note revisions and any commentary on the $1.5B accelerated share repurchase.
- Market reaction to sector moves and geopolitical headlines that recently pressured similar names.
- Any company updates from investor conferences or management interviews that clarify capital allocation and growth priorities.
Sources
Share this report
Share this article
Spread the word on social media
Think VRSK will outperform? Prove it.
Free practice contests — earn Alpha CoinsExplore More Content
Disclaimer: StockAlpha.ai content is for informational and educational purposes only. It is not personalized investment advice. Sentiment ratings and market analysis reflect data-driven observations, not buy, sell, or hold recommendations. Always consult a qualified financial advisor before making investment decisions. Past performance does not guarantee future results.